Publications

Journal Articles

Biocompatible and blood-brain barrier permeable carbon dots for inhibition of Aβ fibrillation and toxicity, and BACE1 activity

Han, X.; Jing, Z.; Wu, W.; Zou, B.; Peng, Z.; Ren, P.; Wikramanayake, A.; Lu, Z.; Leblanc, R. M.

Nanoscale 2017, 9, 12862-12866

Carbon Dots: Diverse Preparation, Application, and Perspective in Surface Chemistry

Yiqun Zhou, Keenan J. Mintz, Shiv K. Sharma, and Roger M. Leblanc

Langmuir 2019, 35, 28, 9115–9132

Crossing the blood-brain-barrier with transferrin conjugated carbon dots: A zebrafish model study

Li, S.; Peng, Z.; Dallman, J.; Baker, J.; Othman, A. M.; Blackwelder, P. L.; Leblanc, R. M.

Colloids Surf. B 2016, 145, 251-6

Dihydrolipoic Acid Conjugated Carbon Dots Accelerate Human Insulin Fibrillation

Kuruvilla S. J., S. Li, L. Sansalone, B. Fortes, I. Zheng, C. Pumilia, M. Micic, J. Orbulescu and R. M. Leblanc

J. Parkinson’s Dis. Alzheimer’s Dis. 2015, 2, 1-7

Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid

Y. Zhou, P.Y. Liyanage, D. Devadoss, L.R.R. Guevara, L. Cheng, R.M. Graham, H.S. Chand, A.O. Al-Youbi, A.S. Bashammakh, M.S. El-Shahawi, R.M. Leblanc

Nanoscale, 2019,11, 22387-22397

Nontoxic Carbon Dots Potently Inhibit Human Insulin Fibrillation

Shanghao Li, Lingyu Wang, Charles C. Chusuei, Valentina M. Suarez, Patrica L. Blackwelder, Miodrag Micic, Jhony Orbulescu and Roger M. Leblanc

Chem. Mater.2015, 27, 5, 1764-1771